Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Synergy Pharma Acquires FV-100 From Bristol-Myers Squibb 12
Partnerships 13
Bind Therapeutics and Synergy Pharma Enter into Research Agreement 13
Licensing Agreements 14
Shandong Luoxin Pharma Enters into Licensing Agreement with Synergy Pharma 14
Cipher Pharma Enters into Licensing Agreement with Synergy Pharma 15
Synergy Pharma Enters Into Agreement With Ironwood Pharma For Plecanatide 16
Equity Offering 17
Synergy Pharma Prices Public Offering of Shares for USD56 Million 17
Synergy Pharma Raises USD125 Million in Public Offering of Shares 19
Synergy Pharma Plans to Raise Funds in Public Offering of Shares 20
Synergy Pharma Raises USD89.8 Million in Private Placement of Shares 21
Synergy Pharma Announces Public Offering Of Shares For Up To US$50 Million 22
ContraVir Pharma Spin Off from Synergy Pharma 23
Synergy Pharma Completes Public Offering Of Shares For US$90 Million 24
Synergy Pharma Completes Exercise Of Underwriters’ Option For Public Offering Of Shares For US$51.75 Million 26
Debt Offering 28
Synergy Pharma Raises USD79.8 Million in Private Placement of Notes Due 2019 28
Synergy Pharma Raises USD200 Million in Private Placement of 7.5% Notes Due 2019 29
Acquisition 31
Synergy Pharma Completes Acquisition Of Callisto Pharma 31
Synergy Pharmaceuticals Inc – Key Competitors 32
Synergy Pharmaceuticals Inc – Key Employees 33
Synergy Pharmaceuticals Inc – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Financial Announcements 35
Aug 07, 2018: Synergy Pharmaceuticals reports second quarter 2018 financial results and business update 35
May 10, 2018: Synergy Pharmaceuticals Reports First Quarter 2018 Financial Results and Business Update 37
Mar 01, 2018: Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Business Update 39
Nov 09, 2017: Synergy Pharmaceuticals Reports Third Quarter 2017 Financial Results 40
Aug 09, 2017: Synergy Pharmaceuticals Reports Second Quarter 2017 Financial Results and Business Update 41
May 10, 2017: Synergy Pharmaceuticals Reports First Quarter 2017 Financial Results and Business Update 43
Mar 01, 2017: Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Business Update 45
Corporate Communications 47
Oct 31, 2018: Synergy Pharmaceuticals names Dr. Melvin K. Spigelman Chairman 47
Apr 17, 2017: Synergy Pharmaceuticals Appoints Gary G. Gemignani as Chief Financial Officer 48
Other Significant Developments 49
Oct 17, 2017: Synergy Pharmaceuticals Presents Results from Study Examining Patient and Physician Perceptions and Experiences with Irritable Bowel Syndrome with Constipation (IBS-C) 49
Appendix 50
Methodology 50
About GlobalData 50
Contact Us 50
Disclaimer 50
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synergy Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Synergy Pharma Acquires FV-100 From Bristol-Myers Squibb 12
Bind Therapeutics and Synergy Pharma Enter into Research Agreement 13
Shandong Luoxin Pharma Enters into Licensing Agreement with Synergy Pharma 14
Cipher Pharma Enters into Licensing Agreement with Synergy Pharma 15
Synergy Pharma Enters Into Agreement With Ironwood Pharma For Plecanatide 16
Synergy Pharma Prices Public Offering of Shares for USD56 Million 17
Synergy Pharma Raises USD125 Million in Public Offering of Shares 19
Synergy Pharma Plans to Raise Funds in Public Offering of Shares 20
Synergy Pharma Raises USD89.8 Million in Private Placement of Shares 21
Synergy Pharma Announces Public Offering Of Shares For Up To US$50 Million 22
ContraVir Pharma Spin Off from Synergy Pharma 23
Synergy Pharma Completes Public Offering Of Shares For US$90 Million 24
Synergy Pharma Completes Exercise Of Underwriters' Option For Public Offering Of Shares For US$51.75 Million 26
Synergy Pharma Raises USD79.8 Million in Private Placement of Notes Due 2019 28
Synergy Pharma Raises USD200 Million in Private Placement of 7.5% Notes Due 2019 29
Synergy Pharma Completes Acquisition Of Callisto Pharma 31
Synergy Pharmaceuticals Inc, Key Competitors 32
Synergy Pharmaceuticals Inc, Key Employees 33
Synergy Pharmaceuticals Inc, Subsidiaries 34
List of Figures
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Synergy Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
【免責事項】
http://www.globalresearch.jp/disclaimer